Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.690
+0.010 (0.60%)
Sep 22, 2026, 5:29 PM CET
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 1.04 billion as of September 22, 2026. Its market cap has increased by 454.19% in one year.
Market Cap
1.04B
Enterprise Value
795.32M
Revenue
8.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.69
ChartMarket Cap Chart
Since April 30, 1999, Medivir AB's market cap has increased from 643.11M to 1.04B, an increase of 62.39%. That is a compound annual growth rate of 1.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 1.04B | 469.09% |
| Dec 30, 2025 | 183.51M | -42.39% |
| Dec 30, 2024 | 318.56M | 100.20% |
| Dec 29, 2023 | 159.12M | -71.16% |
| Dec 30, 2022 | 551.67M | -11.61% |
| Dec 30, 2021 | 624.11M | 209.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 1.52B |
| BioInvent International AB | 1.47B |
| Saniona AB | 1.38B |
| Genovis AB (publ.) | 1.35B |
| AlzeCure Pharma AB | 1.07B |
| SynAct Pharma AB | 1.01B |
| Infant Bacterial Therapeutics AB | 875.64M |
| Oncopeptides AB | 816.66M |